Argenta, the only combined global contract research organization (CRO) and contract development & manufacturing organization (CDMO) dedicated to animal health, announced that it has acquired Klifovet, the leading CRO and Regulatory Affairs consultancy organization in Europe. Financial details of the transaction were not disclosed. Klifovet founder and CEO Dr. Klaus Hellmann will continue to lead Klifovet and will join Argenta’s senior leadership team.

Founded in 1997 by Dr. Klaus Hellmann and located in Munich, Germany, Klifovet has built a leading reputation in the animal health industry, providing extensive expertise in clinical research and regulatory affairs. Its 50 employees have had successful involvement in hundreds of studies, and their expertise and knowledge have been critical to numerous marketing authorisations for pharmaceutical, biological, immunological, and novel therapies. Its client base comprises the world’s top animal health and nutrition companies as well as many promising startups.

“The acquisition of Klifovet, and the expansion into the EU, is part of Argenta’s growth strategy and provides our customers the opportunity for a seamless, global Molecule to Market product development experience,” said Ben Russell, CEO of Argenta. 

The combined business will be a global, full-value strategic partner, stimulating innovation and supporting large and small animal health and nutrition companies. Klifovet will particularly complement Argenta's Clinical & Regulatory Services team based in the United States, offering an unparalleled level of expertise, and access to the largest transatlantic CRO capability in animal health.

“The two leading CROs, with a presence in the EU and US, combined with the know-how and capabilities in manufacturing, regulatory services, project management, and product development, create the world’s leading animal health CDMO and CRO. It provides unique and excellent opportunities for both our clients and employees. I am truly convinced this to be a perfect fit and look forward to a great future within the Argenta Group,” said Klaus Hellmann, CEO of Klifovet.

Argenta was advised on the transaction by Stonehaven Consulting AG, a global consulting firm focused on animal health.